Sort
78,016 grants matching “breast cancer”
DOTA-based pre-targeting of alpha emitters
$489,210Sarah Marie Cheal · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Ultrasonic assessment of therapeutic response
$489,197Katherine W Ferrara · University Of California At Davis · R01 · FY2012 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$489,114Wei R. Chen · University Of Oklahoma · R01 · FY2025 · CA
HHSN261201200020I/HHSN26100006 Title: Preclinical In Vitro And In Vivo Screening Assays For Cancer Preventative Reagent Development, Task Order Title: Evaluation on the Prevention by Actoplus/Met (Pi
$489,093Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2014 · CA
Scott and White Community Clinical Oncology Program
$489,090Scott And White Memorial Hospital · U10 · FY2005 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$489,073Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Engagement Optimization Unit
$489,066Jennifer W Mack · Broad Institute, Inc. · U2C · FY2024 · CA
NYU COOPERATIVE PROSTATE CANCER TISSUE RESOURCE
$489,066New York University School Of Medicine · U01 · FY2003 · CA
The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.
$489,027Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Early Determinants of Mammographic Density
$489,017Mary Beth Terry · Columbia University Health Sciences · R01 · FY2006 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$489,015University Of California San Francisco · R01 · FY2003 · CA
Methods for Epidemiology Studies
$489,013Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models
$489,007Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
MALONYL-COA DECARBOXYLASE (MCD) AS A POTENTIAL THERAPEUTIC TARGET FOR BREAST CANCER
$488,986The Johns Hopkins University · · FY2008 · Department of Defense
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI
$488,977Gregory S Karczmar · University Of Chicago · R01 · FY2016 · CA
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI
$488,977Gregory S Karczmar · University Of Chicago · R01 · FY2017 · CA
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI
$488,977Gregory S Karczmar · University Of Chicago · R01 · FY2015 · CA
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
$488,962Leena A Hilakivi-Clarke · Georgetown University · R01 · FY2012 · CA
ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC
$488,900John R Hawse · Mayo Clinic Rochester · R01 · FY2025 · CA
QUANTITATIVE DUAL-ENERGY CT IMAGING FOR CANCER IMAGING AND RADIATION THERAPY APPLICATIONS
$488,888Joseph A O'Sullivan · Washington University · R01 · FY2017 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2021 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2020 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2018 · CA
Project 1
$488,873Kristen S. Purrington · Wayne State University · P01 · FY2024 · CA
hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin Cardiotoxicity
$488,873Daniel Bernstein · Stanford University · R33 · FY2016 · HL